p53 genotype predicts response to chemotherapy in patients with squamous cell carcinoma of the esophagus.
about
Alterations of the TP53 gene in gastric and esophageal carcinogenesisCIViC databaseCorrelation of p53 status with the response to chemotherapy-based treatment in esophageal cancer: a meta-analysis.Predicting response to neoadjuvant therapy in esophageal cancer.p38δ MAPK phenotype: an indicator of chemotherapeutic response in oesophageal squamous cell carcinomaSystematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer.Pharmacological inhibition of Mdm2 triggers growth arrest and promotes DNA breakage in mouse colon tumors and human colon cancer cellsA systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage.Analysis of AC3-33 gene expression in multiple organ cancer and adjacent normal tissue by RNA in situ hybridizationOverexpression of PFTK1 predicts resistance to chemotherapy in patients with oesophageal squamous cell carcinoma.Assessment of stanniocalcin-1 as a prognostic marker in human esophageal squamous cell carcinoma.APR-246 potently inhibits tumour growth and overcomes chemoresistance in preclinical models of oesophageal adenocarcinoma.Prognosis of esophageal squamous cell carcinoma in patients positive for human epidermal growth factor receptor family can be improved by initial chemotherapy with docetaxel, fluorouracil, and cisplatin.Squamous cell carcinoma in Barrett's esophagus: field effect versus metastasis.Identification of putative target genes for amplification within 11q13.2 and 3q27.1 in esophageal squamous cell carcinoma.Evaluation of the nodal status in the 7th edition of the UICC-TNM classification for esophageal squamous cell carcinoma: proposed modifications for improved survival stratification : impact of lymph node metastases on overall survival after esophagePattern of p53 protein expression is predictive for survival in chemoradiotherapy-naive esophageal adenocarcinoma.PRIMA-1 induces p53-mediated apoptosis by upregulating Noxa in esophageal squamous cell carcinoma with TP53 missense mutation.Peritherapeutic Serum p53 Antibody Titers are Predictors of Survival in Patients with Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemotherapy and Surgery.The Presence of Serum p53 Antibody Predicts the Pathological Tumor Response to Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and Fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma.p53 is an independent prognostic factor in operable esophageal squamous cell carcinoma: a large-scale study with a long follow-up.Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma.Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy.
P2860
Q26866191-6D1989D3-C01A-4680-8148-CB3F5EC3F5DAQ27612411-C8B244E8-954D-43A1-A6B0-81DCE5FC5318Q27852124-DD12BB52-1083-4BA4-8CBB-3C939C2D440CQ34022135-BF324B56-692E-4878-8742-99BFE8653B46Q34570398-3CD27F5D-9834-4AF0-A5B9-18A9045D9430Q35037270-DF32283E-2F86-493C-A6C6-21CD7F1C97D9Q35184378-AF3DF9B8-F188-44FB-A582-A52F5FA97F7DQ35218636-59DC33CA-F111-4C0E-BE1C-5E1221DD5341Q35759010-FCBA5924-A6BC-45B3-8D5F-720EC5FB5D0CQ35835123-47AA847A-FAF2-40F5-80F9-4E73D718D391Q36642821-5C6FFF29-71B8-40C0-86C7-1F8F591414C0Q38851714-5BC45D75-01AE-4797-A5B2-D6BF9B14CDBCQ42726594-7536BE25-13FF-4BFD-83EF-6BA6F87B1952Q43229859-6826D41B-D2E2-4CB8-AB49-86DB98555611Q44694567-682BF3C9-32EC-4293-A90F-37E858C2CB17Q44922322-F0CC43F1-1CB9-4AF2-A3E2-9B0591DEA3B4Q47154860-178E229D-4BD0-4781-BB44-F8EBE310335CQ47371251-58A786C4-F636-43B2-A47C-E6151B7BD2C5Q50941920-3A109B83-629F-4298-9CE5-4F1E58A9025FQ51497796-18BC834C-EE87-44E2-B267-A656A8C595EEQ53015137-FEBA0773-3D03-4282-BA43-DDE59CD1289DQ53064658-B2095B2C-8A05-4EF5-A5BB-45C979961874Q53634507-A7865A3F-468D-409E-B9A3-690D1D4F8350
P2860
p53 genotype predicts response to chemotherapy in patients with squamous cell carcinoma of the esophagus.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
p53 genotype predicts response ...... ll carcinoma of the esophagus.
@ast
p53 genotype predicts response ...... ll carcinoma of the esophagus.
@en
p53 genotype predicts response ...... ll carcinoma of the esophagus.
@nl
type
label
p53 genotype predicts response ...... ll carcinoma of the esophagus.
@ast
p53 genotype predicts response ...... ll carcinoma of the esophagus.
@en
p53 genotype predicts response ...... ll carcinoma of the esophagus.
@nl
prefLabel
p53 genotype predicts response ...... ll carcinoma of the esophagus.
@ast
p53 genotype predicts response ...... ll carcinoma of the esophagus.
@en
p53 genotype predicts response ...... ll carcinoma of the esophagus.
@nl
P2093
P2860
P1476
p53 genotype predicts response ...... ll carcinoma of the esophagus.
@en
P2093
Hiroshi Miyata
Jin Matsuyama
Kiyokazu Nakajima
Makoto Yamasaki
Shuji Takiguchi
Takushi Yasuda
Toshirou Nishida
Yoshiyuki Fujiwara
P2860
P2888
P304
P356
10.1245/S10434-009-0851-4
P577
2010-02-01T00:00:00Z
P6179
1007021952